-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
CS-M1995
![{PARAM:[Name]}({[CAS]})](https://resource.bocsci.com/structure/876707-99-2.gif)
| Category | Hepatitis C Virus (HCV) |
| CAS | 876707-99-2 |
| Description | CS-M1995 is a 4'-Azidocytidine analogue. It can inhibit Hepatitis C virus replication. |
Product Information
| Synonyms | CS-M1995; CS M1995; CSM1995; Nucleoside-Analog-1;6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one, 2-azido-2,3,3a,9a-tetrahydro-3-hydroxy-2-(hydroxymethyl)-, (2R,3S,3aS,9aR)-;(2R,3S,3aS,9aR)-2-azido-3-hydroxy-2-(hydroxymethyl)-3a,9a-dihydro-3H-furo[1,2][1,3]oxazolo[3,4-a]pyrimidin-6-one |
| IUPAC Name | (2R,4R,5S,6S)-4-azido-5-hydroxy-4-(hydroxymethyl)-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one |
| Molecular Weight | 267.20 |
| Molecular Formula | C9H9N5O5 |
| Canonical SMILES | C1=CN2C3C(C(C(O3)(CO)N=[N+]=[N-])O)OC2=NC1=O |
| InChI | InChI=1S/C9H9N5O5/c10-13-12-9(3-15)6(17)5-7(19-9)14-2-1-4(16)11-8(14)18-5/h1-2,5-7,15,17H,3H2/t5-,6-,7+,9+/m0/s1 |
| InChIKey | HXIRTOCBJXONPW-XZMZPDFPSA-N |
| Purity | >98 % |
| Solubility | 10 mM in DMSO |
| Appearance | Solid powder |
| Application | CS-M1995 can inhibit Hepatitis C virus replication. |
| Shelf Life | 2 month in rt, long time |
| Storage | -20°C Freezer |
| Complexity | 541 |
| Exact Mass | 267.06036840 |
| PSA | 143.56000 |
| Target | Nucleoside Antimetabolite/Analog; HCV |
| XLogP3-AA | -0.4 |